VNDA

Vanda Pharmaceuticals Inc. News Headlines

$11.13
*  
0.14
1.24%
Get VNDA Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading VNDA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Use Options For a Chance To Buy VNDA at a 44% Discount
1/9/2015 12:12:12 PM - BNK Invest


Cellceutix Overvalued By 90-99%
1/2/2015 5:21:00 PM - Seeking Alpha


Vanda Pharmaceuticals shares bought
12/26/2014 11:31:00 AM - InvestorsObserver


Vanda Gains Fanapt Rights from Novartis for the U.S. Region - Analyst Blog
12/24/2014 4:30:00 PM - Zacks.com


Why the bulls are chasing Vanda
12/24/2014 6:16:24 AM - optionMONSTER


Vanda Gains Fanapt Rights from Novartis for the U.S. Region - Analyst Blog
12/24/2014 4:30:00 AM - Investopedia


Health Care Sector Update for 12/23/2014: VNDA,NVS,CRMD,ACHN
12/23/2014 1:06:56 PM - MT Newswires


European Extend Rally On Robust U.S. GDP -- Canadian Commentary
12/23/2014 12:14:00 PM - RTT News


Mid-Morning Market Update: Markets Mostly Higher; Walgreen Profit Beats Expectations
12/23/2014 10:40:17 AM - Benzinga


Vanda Pharmaceuticals Inc. (VNDA) Is Up Sharply After Novartis Settlement
12/23/2014 9:35:00 AM - RTT News


U.S. Hot Stocks: Hot Stocks to Watch
12/23/2014 9:04:00 AM - Dow Jones Business News


US Stocks Poised For Flat Open Ahead Of Data Deluge
12/23/2014 6:30:00 AM - RTT News


Vanda Settle Fanapt Arbitration With Novartis
12/22/2014 7:14:00 PM - RTT News


Vanda, Novartis Settle Drug Licensing Dispute
12/22/2014 5:55:00 PM - Dow Jones Business News


Vanda, Novartis Settle Licensing Dispute Over Schizophrenia Drug
12/22/2014 5:29:00 PM - Dow Jones Business News


Use Options For a Chance To Buy VNDA at a 30% Discount
12/11/2014 11:55:46 AM - BNK Invest


Vanda Pharma To Present At Piper Jaffray Conference; Webcast At 2:30 PM ET
12/3/2014 1:30:00 PM - RTT News


Idera Pharma Appoints Vincent Milano As CEO
12/2/2014 12:04:00 AM - RTT News


Vanda Pharma Present At Stifel Nicolaus Conference; Webcast At 11:30 AM ET
11/19/2014 10:31:00 AM - RTT News


Commit To Buy Vanda Pharmaceuticals At $7, Earn 15% Using Options
11/6/2014 11:54:16 AM - BNK Invest


Sector Update: Health-Care Shares Flat Before Opening Bell
10/27/2014 7:49:25 AM - MT Newswires


Sector Update: Health Care
10/27/2014 7:45:32 AM - MT Newswires


Vanda Up on EU News - Analyst Blog
6/5/2014 6:01:00 PM - Zacks.com


Wednesday's ETF Movers: XBI, GXC
6/4/2014 2:23:26 PM - BNK Invest


Healthcare Stocks Mixed; Vanda Pharmaceutical Adds More Than 25% After 'Non-24' Medication Wins Orphan Drug Status in Europe
6/4/2014 12:43:29 PM - MT Newswires